Physician profile
Robert Potorski
NPI 1063455756
$1,460.11
in general payments reported to CMS, 2019-2025
23 companies · $28.21 in 2025
The $28.21 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $308 · 2021: $472 · 2022: $260 · 2023: $41.76 · 2025: $28.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $69.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $69.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $206.07 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $171.29 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $167.85 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $112.92 | 2020-2022 | |
| Edwards Lifesciences Corporation | $82.28 | 2019-2020 | |
| Pfizer INC. | $77.00 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.33 | 2019-2022 | |
| Abbott Laboratories | $73.72 | 2020-2023 | Cardiomems |
| Boston Scientific Corporation | $70.25 | 2020-2023 | |
| E.R. Squibb & Sons, L.L.C. | $66.94 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $61.67 | 2019 | |
| Philips North America LLC | $46.96 | 2020-2025 | Ecc Solutions |
| Bayer Healthcare Pharmaceuticals INC. | $40.96 | 2021-2022 | |
| Astellas Pharma US INC | $30.87 | 2021-2022 | |
| Baxter Healthcare | $26.31 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $22.29 | 2019 | |
| Medtronic Vascular, INC. | $20.89 | 2019 | |
| Heartflow, INC. | $19.93 | 2019 | |
| Preventice Services, LLC | $18.77 | 2020 | |
| Medtronic, INC. | $18.70 | 2021 | |
| Merck Sharp & Dohme LLC | $17.02 | 2021 | |
| Esperion Therapeutics, INC. | $15.82 | 2021 | |
| Medicomp INC | $15.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Potorski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.